(Q33299027)

English

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study (English)

1 reference

Europe PubMed Central

25 July 2017

autosomal dominant polycystic kidney disease

0 references

1 reference

based on heuristic

inferred from title

autosomal dominant polycystic kidney

1 reference

based on heuristic

inferred from title

author name string

Andreas L Serra

1

1 reference

Europe PubMed Central

25 July 2017

Andreas D Kistler

2

1 reference

Europe PubMed Central

25 July 2017

Diane Poster

3

1 reference

Europe PubMed Central

25 July 2017

Marian Struker

4

1 reference

Europe PubMed Central

25 July 2017

Rudolf P Wüthrich

5

1 reference

Europe PubMed Central

25 July 2017

Dominik Weishaupt

6

1 reference

Europe PubMed Central

25 July 2017

Frank Tschirch

7

1 reference

Europe PubMed Central

25 July 2017

publication date

15 September 2007

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

8

1 reference

Europe PubMed Central

25 July 2017

13

1 reference

Europe PubMed Central

25 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

15 September 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2369-8-13

0 references

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Molecular genetics of autosomal recessive polycystic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2048941

21 June 2018

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-8-13

21 January 2018

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-8-13

21 January 2018

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-8-13

21 January 2018

Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17868472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Volume of polycystic kidneys during reduction of renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/17868472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rate of functional deterioration in polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17868472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Volume progression in polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17868472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polycystic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17868472

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2369-8-13

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-8-13

9 September 2019

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33299027&oldid=1956449292"